Delta Financial Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History

Delta Financial Advisors LLC

$265 Million
Q4 2024

A detailed history of Delta Financial Advisors LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Delta Financial Advisors LLC holds 1,353 shares of REGN stock, worth $858,113. This represents 0.36% of its overall portfolio holdings.

Number of Shares

1,353

Previous 1,355 0.15%

Holding current value

$858,113

Previous $1.42 Million 32.37%

% of portfolio

0.36%

Previous 0.52%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	SELL	$701.85 - $1046.91 $1,403 - $2,093	-2 Reduced 0.15%	1,353 $963,000
Q3 2024 Nov 04, 2024	SELL	$1024.09 - $1201.76 $40,963 - $48,070	-40 Reduced 2.87%	1,355 $1.42 Million
Q1 2024 May 07, 2024	BUY	$902.69 - $993.35 $13,540 - $14,900	15 Added 1.09%	1,395 $1.34 Million
Q4 2023 Jan 31, 2024	BUY	$775.18 - $881.7 $77,518 - $88,170	100 Added 7.81%	1,380 $1.21 Million
Q2 2023 Aug 03, 2023	SELL	$700.03 - $830.35 $24,501 - $29,062	-35 Reduced 2.66%	1,280 $919,000
Q1 2023 May 04, 2023	SELL	$680.49 - $826.97 $27,219 - $33,078	-40 Reduced 2.95%	1,315 $1.08 Million
Q3 2022 Oct 27, 2022	SELL	$573.97 - $724.32 $2,869 - $3,621	-5 Reduced 0.37%	1,355 $933,000
Q1 2022 May 06, 2022	BUY	$595.12 - $698.43 $2,975 - $3,492	5 Added 0.37%	1,360 $950,000
Q4 2021 Feb 04, 2022	BUY	$543.48 - $670.97 $2,717 - $3,354	5 Added 0.37%	1,355 $856,000
Q3 2021 Oct 26, 2021	SELL	$574.03 - $680.96 $5,740 - $6,809	-10 Reduced 0.74%	1,350 $817,000
Q2 2021 Aug 04, 2021	BUY	$472.8 - $558.54 $38,296 - $45,241	81 Added 6.33%	1,360 $760,000
Q1 2021 Apr 29, 2021	BUY	$446.73 - $548.2 $38,418 - $47,145	86 Added 7.21%	1,279 $605,000
Q4 2020 Jan 28, 2021	BUY	$478.3 - $607.98 $50,221 - $63,837	105 Added 9.65%	1,193 $576,000
Q3 2020 Oct 20, 2020	BUY	$544.75 - $658.21 $19,066 - $23,037	35 Added 3.32%	1,088 $609,000
Q2 2020 Aug 04, 2020	BUY	$493.32 - $643.92 $29,599 - $38,635	60 Added 6.04%	1,053 $657,000
Q1 2020 Apr 27, 2020	BUY	$336.18 - $494.43 $118,671 - $174,533	353 Added 55.16%	993 $485,000
Q4 2019 Feb 06, 2020	BUY	$274.13 - $376.51 $175,443 - $240,966	640 New	640 $240,000

Others Institutions Holding REGN

# of Institutions

1,496

Shares Held

85.8M

Call Options Held

1.53M

Put Options Held

1.44M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $68B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Delta Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Delta Financial Advisors LLC with notifications on news.

Account

Delta Financial Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History